These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7980085)

  • 1. [The use of anticoagulants in patients with congestive heart failure].
    da Silva MA
    Arq Bras Cardiol; 1994 Mar; 62(3):205. PubMed ID: 7980085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulation in patients with congestive heart failure].
    Furtado MA; Barretto AC
    Arq Bras Cardiol; 1994 Mar; 62(3):201-4. PubMed ID: 7980084
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticoagulation in chronic heart failure and left ventricular dysfunction].
    Wichter T; Breithardt G
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2145-8. PubMed ID: 12397561
    [No Abstract]   [Full Text] [Related]  

  • 4. Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?
    Katz SD
    J Cardiovasc Risk; 1995 Apr; 2(2):97-102. PubMed ID: 7606657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we use anticoagulation for patients with chronic heart failure?
    Freudenberger RS; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):580-1. PubMed ID: 17063158
    [No Abstract]   [Full Text] [Related]  

  • 6. [For which patients with cardiac decompensation is prevention of thromboembolism advisable?].
    G Ital Cardiol; 1994 Oct; 24(10):1341-6. PubMed ID: 7835568
    [No Abstract]   [Full Text] [Related]  

  • 7. [The embolic risk and oral anticoagulant therapy in chronic heart failure].
    Urbinati S; Pinelli G; Maggioni AP; Zaccaroni S; Gorini M; Lucci D
    G Ital Cardiol; 1999 Feb; 29(2):183-92. PubMed ID: 10088077
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulation in patients with atrial fibrillation and congestive heart failure.
    Veloso HH; de Paola AA
    Am J Cardiol; 2005 Jun; 95(12):1533. PubMed ID: 15950594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of thrombosis in heart insufficiency with Solvosal-Heparin].
    Kunzmann G; Stingl J
    Med Welt; 1970 Aug; 31():1388-90. PubMed ID: 5510238
    [No Abstract]   [Full Text] [Related]  

  • 10. What do we know about anticoagulation in patients with heart failure?
    Ahnert AM; Freudenberger RS
    Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thromboembolic risk in chronic cardiac insufficiency].
    Tavazzi L
    Rev Port Cardiol; 1997 Sep; 16(9):723-4. PubMed ID: 9409939
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulant treatment and cardiac insufficiency].
    Bounhoure JP; Galinier M; Pathak A
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():29-32. PubMed ID: 10830086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy in heart failure.
    Verheugt FW
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):277-8. PubMed ID: 16716103
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.
    Kleber FX; Witt C; Vogel G; Koppenhagen K; Schomaker U; Flosbach CW;
    Am Heart J; 2003 Apr; 145(4):614-21. PubMed ID: 12679756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anticoagulant therapy in patients with dilated cardiomyopathy].
    Gensini GF; Rostagno C
    Ann Ital Med Int; 1998; 13(4):227-32. PubMed ID: 10349204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Venous thromboembolism risk in medical inpatients].
    Dini F; Moruzzo D; Bindi M; Pinelli M; Castiglioni M
    Recenti Prog Med; 2008; 99(7-8):354-62. PubMed ID: 18751614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of venous thromboembolism among hospitalized medical patients.
    Goldhaber SZ; Turpie AG
    Circulation; 2005 Jan; 111(1):e1-3. PubMed ID: 15630031
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?
    Herijgers P; Verhamme P
    Eur Heart J; 2007 Oct; 28(20):2424-6. PubMed ID: 17890728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of anticoagulants in the treatment of cardiac insufficiency in patients with rheumatic defects of the heart].
    Kushelevskiĭ BP; Rozhdestvenskaia ED
    Sov Med; 1967 Jul; 30(7):28-32. PubMed ID: 5607868
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.